Abstract:Purinergic signaling was proposed in 1972, after it was demonstrated that adenosine 5'-triphosphate (ATP) was a transmitter in nonadrenergic, noncholinergic inhibitory nerves supplying the guinea-pig taenia coli. Later, ATP was identified as an excitatory cotransmitter in sympathetic and parasympathetic nerves, and it is now apparent that ATP acts as a cotransmitter in most, if not all, nerves in both the peripheral nervous system and central nervous system (CNS). ATP acts as a short-term signaling molecule in neurotransmission, neuromodulation, and neurosecretion. It also has potent, long-term (trophic) roles in cell proliferation, differentiation, and death in development and regeneration. Receptors to purines and pyrimidines have been cloned and characterized: P1 adenosine receptors (with four subtypes), P2X ionotropic nucleotide receptors (seven subtypes) and P2Y metabotropic nucleotide receptors (eight subtypes). ATP is released from different cell types by mechanical deformation, and after release, it is rapidly broken down by ectonucleotidases. Purinergic receptors were expressed early in evolution and are widely distributed on many different nonneuronal cell types as well as neurons. Purinergic signaling is involved in embryonic development and in the activities of stem cells. There is a growing understanding about the pathophysiology of purinergic signaling and there are therapeutic developments for a variety of diseases, including stroke and thrombosis, osteoporosis, pain, chronic cough, kidney failure, bladder incontinence, cystic fibrosis, dry eye, cancer, and disorders of the CNS, including Alzheimer's, Parkinson's. and Huntington's disease, multiple sclerosis, epilepsy, migraine, and neuropsychiatric and mood disorders.

Purinergic Signaling: A Fundamental Mechanism in Neutrophil Activation

Purinergic Regulation of Neutrophil Function

Purinergic Signaling： a Novel Mechanism in Immune Surveillance

Purinergic regulation of the immune system

Purinergic signalling and immune cells

Purinergic P2 Receptors: Novel Mediators of Mechanotransduction

P2RX1-Involved Glycolytic Metabolism Supports Neutrophil Activation in Acute Pancreatitis

Signaling by Neutrophil G Protein-Coupled Receptors that Regulate the Release of Superoxide Anions

Introduction to Purinergic Signaling

Purinergic Signaling in Pulmonary Inflammation

Purinergic signaling and the functioning of the nervous system cells

Purine and purinergic receptors in health and disease

Neutrophil cell surface receptors and their intracellular signal transduction pathways

Receptor-Mediated NETosis on Neutrophils

Endotoxin-Induced Autocrine Atp Signaling Inhibits Neutrophil Chemotaxis Through Enhancing Myosin Light Chain Phosphorylation

Purinergic signalling in liver diseases: Pathological functions and therapeutic opportunities

ATP-release pannexin channels are gated by lysophospholipids

Role of purinoreceptors in the release of extracellular vesicles and consequences on immune response and cancer progression

Purinergic enzymes on extracellular vesicles: immune modulation on the go

GPR97 triggers inflammatory processes in human neutrophils via a macromolecular complex upstream of PAR2 activation

ATP Release and Purinergic Signaling: a Common Pathway for Particle-Mediated Inflammasome Activation